Form D Explorer
Project Nootropic Ltd · CIK 2080713

Report a data issueCitable research briefCompare issuerPrivate research collection

Project Nootropic Ltd

CIK 2080713 · Corporation · Inc. UNITED KINGDOM · LONDON, United Kingdom · Other

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filing history at a glance

The reported offering amount was $1,067,520 in the Jun 8, 2026 filing and $1,092,000 in the Jul 15, 2026 filing. The two records may concern different offerings. From Aug 11, 2025 to Jul 15, 2026, the explorer stores 2 original notices and 1 amendments.

Filings
3
Original notices
2
Amendments
1
Activity
Aug 11, 2025
through Jul 15, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldJun 8, 2026 · DJul 15, 2026 · D/ALater minus earlier
Reported offering amount$1,067,520$1,092,000$24,480
Reported amount sold$1,067,520$1,086,720$19,200
Reported investor count13152
Reported minimum investment$10,000$10,000$0

Earlier SEC source: 0002080713-26-000001 · Later SEC source: 0002080713-26-000002

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D/A · Jul 15, 2026

Reported offering amount
$1,092,000
Reported exemptions
Rule 506(b)
Reported amount sold
$1,086,720

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Filings by year

Submission counts, including amendments; not dollars raised or distinct funding rounds.

Form D filings (3)